Component stocks Rapport Therapeutics fell 20.12%, Anavex Life Sciences dropped 13.50%, BeOne Medicines DRC decreased by 10.68%, and Zai Lab ADR declined 9.81%, ranking fourth from the bottom.
Amylyx Pharmaceuticals rose 12.56%, ranking third, Trevi Therapeutics increased by 14.13%, and Travere Therapeutics surged 26.21%

TRVI

The Nasdaq Technology Index fell by more than 1.3%. Among the constituent stocks, Rapport Therapeutics dropped 20.12%, Anavex Life Sciences fell 13.50%, BeOne Medicines DRC decreased 10.68%, and Zai Lab ADR declined 9.81%. Meanwhile, Amylyx Pharmaceuticals rose 12.56%, Trevi Therapeutics increased 14.13%, and Travere Therapeutics surged 26.21%. Trump has called for the pharmaceutical industry to improve the transparency of drug risks

纳指科技指数收跌超 1.3%，特朗普要求医药行业提高药品的风险透明度